Lisata Therapeutics, Inc.

Rentabilité sur six mois: -4.04%
Rendement en dividendes: 0%
Secteur: Healthcare

2.5 $

0 $ 0%
1.9 $
3.9 $

paper.min_max_per_year

Calendrier des promotions Lisata Therapeutics, Inc.

À propos de l'entreprise Lisata Therapeutics, Inc.

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 1b/2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; HONEDRA, a recipient of SAKIGAKE designation critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysfunction; and LSTA201, a CD34+ cell therapy for the treatment of chronic kidney disease. The company was formerly known as NeoStem, Inc. and changed its name to Caladrius Biosciences, Inc. in June 2015. The company was formerly known as Caladrius Biosciences, Inc. and changed its name to Lisata Therapeutics, Inc. on September 15, 2022. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.

Paramètres de base

IPO date
1999-03-01
ISIN
US1280583022
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт

Grade

Sous-estimation
Nom Signification Grade
P/S 24.49 1
P/BV 0.8353 9
P/E 0 0
Efficacité
Nom Signification Grade
ROA -44.56 0
ROE -51.43 0
ROIC 0 0
Dividendes
Nom Signification Grade
Rendement en dividendes 0 0
DSI 0 0
Croissance moyenne du dividende 0 0
Devoir
Nom Signification Grade
Debt/EBITDA -0.0066 10
Debt/Ratio 0.0039 10
Debt/Equity 0.1939 10
Impulsion de croissance
Nom Signification Grade
Rentabilité Revenue, % -94.43 0
Rentabilité Ebitda, % 7.9 1
Rentabilité EPS, % -69.67 0

paper.price.prices

Prix Common.min. Common.max. Changement paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 2.5 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 2.46 $ 0 $ 0 $ 1.42 % 0 % 0 %
common.calendar.number_days.30d 2.7 $ 2.46 $ 2.69 $ -7.59 % 0 % 0 %
common.calendar.number_days.90d 1.95 $ 1.9 $ 2.74 $ 27.95 % 0 % 0 %
common.calendar.number_days.180d 2.6 $ 1.9 $ 3.9 $ -4.04 % 0 % 0 %
common.calendar.number_days.1y 2.75 $ 1.9 $ 3.9 $ -9.27 % 0 % 0 %
common.calendar.number_days.3y 7.4 $ 0.48 $ 7.66 $ -66.28 % 0 % 0 %
common.calendar.number_days.5y 2.45 $ 0.41 $ 7.66 $ 1.84 % 0 % 0 %
common.calendar.number_days.10y 0.41 $ 0.41 $ 8.64 $ 608.54 % 0 % 0 %
common.calendar.number_days.ytd 2.71 $ 1.9 $ 3.9 $ -8.07 % 0 % 0 %

Principaux propriétaires

Entreprises similaires



Gestion d'entreprise

Superviseur Titre d'emploi Paiement Année de naissance
Dr. David J. Mazzo B.A. (Hons), B.Sc. (Hons.), M.Sc., Ph.D. President, CEO & Director 1.16M 1957 (68 années)
Dr. Kristen K. Buck M.D. Executive VP of R&D and Chief Medical Officer 938.42k 1974 (51 année)
Mr. James Nisco Senior VP of Finance, Treasurer, CAO & Principal Financial and Accounting Officer N/A 1971 (54 année)
Mr. Tariq Imam Vice President of Business Development & Operations and Corporate Counsel N/A
Mr. Gregory S. Berkin Chief Information Officer N/A
Mr. John D. Menditto Vice President of Investor Relations & Corporate Communications N/A
Ms. Gail Holler Vice President of Human Resources N/A 1959 (66 années)
Dr. William K. Sietsema Ph.D. Vice President of Global Regulatory Affairs 350.55k 1956 (69 années)

Informations sur l'entreprise

Adresse: United States, Basking Ridge. NJ, 110 Allen Road - Ouvrir dans google maps, Ouvrir les cartes yandex
Site web: https://www.lisata.com